
National Research Corporation NRC
$ 18.05
1.06%
Quarterly report 2026-Q1
added 05-06-2026
National Research Corporation P/E Ratio 2011-2026 | NRC
Annual P/E Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.2 | 13.5 | 32.6 | 35.8 | 28.2 | 30.4 | 53 | 35.4 | 39.2 | 20.3 | 20.8 | 18.5 | 24.2 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53 | 13.5 | 29.1 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
-19.5 | $ 19.84 | -19.84 % | $ 575 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 17.17 | 0.94 % | $ 181 M | ||
|
Agilent Technologies
A
|
34.7 | $ 118.22 | 0.38 % | $ 35.9 B | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 21.41 | 2.24 % | $ 1.14 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 1.8 | 9.76 % | $ 2.39 M | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 429.06 | 0.53 % | $ 12.4 B | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.05 | -1.58 % | $ 375 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 8.96 | 0.79 % | $ 1.15 B | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 186.83 | 2.81 % | $ 9.26 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-9.69 | $ 213.51 | -0.73 % | $ 21 B | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 15.03 | 0.74 % | $ 454 M | ||
|
Koninklijke Philips N.V.
PHG
|
33.8 | $ 27.4 | 0.74 % | $ 26 B | ||
|
Personalis
PSNL
|
-3.12 | $ 5.92 | -2.54 % | $ 351 M | ||
|
Guardant Health
GH
|
-32.3 | $ 89.17 | -3.34 % | $ 11.2 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | $ 52.92 | -0.04 % | $ 2.69 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 124.3 | 0.14 % | $ 10.3 B | ||
|
Illumina
ILMN
|
-13.4 | $ 138.37 | -2.95 % | $ 22 B | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 5.17 | -3.54 % | $ 216 M | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 2.04 | -3.33 % | $ 9.02 M | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.17 | -1.84 % | $ 4.98 M | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 470.89 | -0.52 % | $ 178 B | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 90.77 | 5.36 % | $ 6.13 B | ||
|
Trinity Biotech plc
TRIB
|
-6.21 | $ 0.61 | 1.35 % | $ 219 M | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 258.01 | 0.41 % | $ 21.5 B | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 58.65 | -1.48 % | $ 3.51 B | ||
|
Celcuity
CELC
|
-30.3 | $ 128.71 | -7.7 % | $ 6.02 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.22 | 0.44 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 189.5 | 0.2 % | $ 21 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M |